Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MHLW To Establish ¥150 Billion Fund For Avian Flu Vaccine Production 

This article was originally published in PharmAsia News

Executive Summary

The Ministry of Health, Labor and Welfare proposed establishing a fund to finance manufacturing avian flu vaccines that can be produced for all citizens within six months following an avian flu outbreak. The ¥150 billion avian flu fund will be funded by special budget requests appropriated through several years. A project team inside the ruling Liberal Democrat Party has accepted the proposal. The ministry plans to use the fund to provide financial support to vaccine manufacturers that are conducting research to shorten production time from using animal cells instead of eggs. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071516

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel